logo
Reserve Bank expands exemptions under Large Exposures Framework for Priority Sector Lending Shortfalls

Reserve Bank expands exemptions under Large Exposures Framework for Priority Sector Lending Shortfalls

The Reserve Bank of India (RBI) has issued notification yesterday, expanding the scope of exemptions under its Large Exposures Framework (LEF). According to the notification, RBI modifies paragraph 3.1 of the LEF to broaden the scope of entities for which exposures can be excluded from the LEF limits. Under the earlier provisions, banks were allowed to exclude from LEF calculations only those deposits maintained with the National Bank for Agriculture and Rural Development (NABARD) made on account of shortfalls in meeting Priority Sector Lending (PSL) targets. The RBI has now extended this exemption to include similar contributions made to: National Housing Bank (NHB) Small Industries Development Bank of India (SIDBI) Micro Units Development and Refinance Agency Ltd. (MUDRA Ltd.) Any other entity specified by the RBI The updated rule clarifies that these exclusions apply only when the contributions are made to offset PSL shortfalls. By revising paragraph 3.1 of the LEF, the RBI has effectively increased the range of permissible exemptions under the exposure norms, granting banks greater flexibility in managing their credit exposure portfolios.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Stock Market Updates: Sensex, Nifty Volatile At Open; Paytm Tanks 8%
Stock Market Updates: Sensex, Nifty Volatile At Open; Paytm Tanks 8%

News18

timean hour ago

  • News18

Stock Market Updates: Sensex, Nifty Volatile At Open; Paytm Tanks 8%

Last Updated: Indian equity benchmarks, Sensex and Nifty, are poised for a cautious yet positive start on Thursday Indian equity benchmarks, Sensex and Nifty, are poised for a cautious yet positive start on Thursday, supported by a mix of domestic and global cues. Investors will closely track India's May inflation numbers, global market trends, and updates on the US-China trade deal. At around 8:15 AM, GIFT Nifty futures were up 55 points at 25,267, hinting at a firm opening for domestic markets. Domestic Focus CPI Data in Spotlight India's consumer price inflation for May is expected to have cooled to a six-year low of 3%, aided by a favourable base and easing food prices, according to a Reuters poll. This aligns with the RBI's surprise 50 basis point repo rate cut last week, aimed at supporting growth amid a disinflationary trend. Global Market Cues Asia-Pacific markets traded mixed on Thursday as investors evaluated the US President Donald Trump's announcement that a trade agreement with China was 'done,' though key details and implications left room for caution. Trump indicated that Chinese imports would face a total tariff rate of 55 per cent, a level later confirmed by the US Commerce Secretary Howard Lutnick. Last checked, Nikkei was down 0.75 per cent, while the broader Topix dropped 0.43 per cent. ASX200 was trading flat with a negative bias. Kospi, bucking the trend, rose 0.4 per cent. Meanwhile, US stock futures edged lower as markets digested the tentative trade deal and fresh inflation data. Futures tied to the S&P 500 and Nasdaq 100 were down 0.2 per cent, while Dow Jones futures dropped 0.2 per cent. The US consumer price index (CPI) rose just 0.1 per cent in May, below the 0.2 per cent forecast, while core CPI, which strips out food and energy, also came in weaker than expected. The modest inflation reading added to the cautious tone across global markets. On Wall Street, major indexes closed slightly lower overnight, pausing after a recent rally. Dow Jones ended flat with a negative bias, S&P 500 slipped 0.27 per cent, and Nasdaq closed 0.5 per cent lower. President Trump noted on Truth Social that the trade deal with China is 'done, subject to final approval with President Xi and me." The deal reportedly includes upfront Chinese supply of rare earths and magnets, while the US will ease restrictions on Chinese students studying in the US. Trump further said, 'We are getting a total of 55 per cent tariffs, China is getting 10 per cent." Additionally, US PPI and core PPI figures for May, and initial jobless claims for the week ended June 7 will also be eyed. First Published: June 12, 2025, 09:17 IST News business » markets Stock Market Updates: Sensex, Nifty Volatile At Open; Paytm Tanks 8%

Growth boost or caution flag? RBI sends conflicting signals with surprise moves
Growth boost or caution flag? RBI sends conflicting signals with surprise moves

Time of India

timean hour ago

  • Time of India

Growth boost or caution flag? RBI sends conflicting signals with surprise moves

India's central bank under new Governor Sanjay Malhotra is giving market participants conflicting signals about monetary policy as it takes aggressive steps to spur economic growth and lending. The Reserve Bank of India surprised analysts last week by cutting interest rates more than expected and announcing a cash boost for banks, citing the need to spur growth. Yet, at the same time, it changed the policy stance back to neutral after just one meeting, a relatively hawkish signal on future rate cuts. Malhotra — who has been in the role for six months now — said at the time there's 'very limited space to support growth.' Taken together, the message is a 'somewhat confusing policy signal,' said Priyanka Kishore, principal economist at Asia Decoded Pte Ltd. in Singapore. 'This lack of clarity could potentially hinder the effective transmission of interest rate cuts, thereby undermining the policy's objectives.' by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like When the Camera Clicked at the Worst Possible Time Read More Malhotra is seeking to boost growth after recent data showed the economy grew 6.5% in the past fiscal year, well below the 8% Prime Minister Narendra Modi needs to meet his ambitious goals for the nation. Yet despite three rate cuts under the new governor, consumers and businesses are reluctant to borrow, leading banks to park much of that cash rather than lend it out. Bloomberg Live Events You Might Also Like: RBI's 50 bps rate cut surprise: Two economists who beat the crowd are back with another call The central bank didn't respond to an email seeking comment. Recent liquidity steps taken by the RBI also appear to be contradictory to some analysts. Despite excess funds in the market, the RBI said last week it will cut the cash reserve ratio for banks in a phased manner — a move that will pump 2.5 trillion rupees ($29.2 billion) into the banking system from September. On Monday, the RBI then announced it will discontinue daily liquidity injections, leading to speculation the central bank's next move may be actively withdrawing excess cash from the market. 'With banking system liquidity ample, the need to use a blunt tool like the CRR is unclear,' Sonal Varma, chief economist for Asia ex-Japan at Nomura Holdings Ltd. in Singapore, said after the RBI's policy decision last week. You Might Also Like: RBI said to use cash reserve ratio as active liquidity tool The RBI's moves triggered volatility in bond yields, prompting two state-run companies to scrap their plans to sell rupee-denominated debt. The average yield on top-rated three- and five-year corporate debt rose eight basis points and nine basis points, respectively, this week after dropping 4-5 basis points after the central bank's liquidity boost on Friday. Loan Growth The CRR cut comes on top of a record 9.5 trillion rupees of liquidity already pumped into the banking system since January. With credit demand remaining sluggish though, banks are parking the excess funds with the RBI rather than extending loans. As of June 10, banks had deposited 2.7 trillion rupees in the central bank's overnight facility. Meanwhile, India's loan growth dipped below 10% last month for the first time in more than three years, according to RBI data. The excess funds in the system have dragged rates on secured money market instruments far below the RBI's policy rate of 5.5% and even lower than the central bank's interest rate floor. You Might Also Like: RBI to cut CRR by 100 bps in four tranches to boost liquidity, effective Sept The new monetary policy committee under Malhotra has made a shift from the past by using the policy stance as a tool of forward guidance on interest rates, said A. Prasanna, chief economist at ICICI Securities Primary Dealership Ltd., a bond trading firm. In the past, the stance represented the RBI's comprehensive view on liquidity, interest rates, money supply, and credit conditions, he said. 'We are not used to such guidance, so it may be confusing for market participants, depending on their expectations from policy,' Prasanna said. You Might Also Like: RBI's big-bang policy approach has no room for incrementalism

Jyotivardhan Jaipuria on where to put money on the table and where to take it off
Jyotivardhan Jaipuria on where to put money on the table and where to take it off

Economic Times

time2 hours ago

  • Economic Times

Jyotivardhan Jaipuria on where to put money on the table and where to take it off

Other than banks and financials, Jyotivardhan Jaipuria, Founder & MD, Valentis Advisors, favours the Chemical sector which is gaining attention due to low dealer stocking levels. Cement sector is expected to benefit from consolidation and government demand. Pharma, especially CDMO, shows growth potential. US generics are attractive on corrections. Small and mid-caps offer stronger earnings growth, but valuation is key. Liquidity will drive earnings for small and mid-caps. The increase in the excise duty by the Maharashtra government has come as a bit of a shocker for the consumers and for alcobev companies as well. It is the highest ever hike that we have seen since 2011 on Indian made foreign liquor (IMFL), it is in the range of 50% to 60% which is likely to lead to an MRP hike of almost 30% to 50% for the brands. How do you see the alcobev pack playing out because analysts were getting incrementally bullish on the consumer discretionary, especially the alcobev part. How will this shape up now? Jyotivardhan Jaipuria: We do not own these stocks and that has been one of our concerns that all of these are very dependent on government policies and it is dependent on each state and very often the states keep changing duties and so that is what starts affecting the demand. If I look at a very macro picture what we have to remember is lot of states are struggling for revenue and when they are struggling for revenue because of the subsidies they have given or the election promises they have given, stuff like alcohol becomes one very easy target from where they can raise avenues because it is treated as this is for the rich people, it is not for the poor people and that has been our concern really that it is very difficult to keep forecasting what each state does over here. We generally stayed away from this pack. This is going to be negative for demand for the sector. Before we discuss more of your sectoral bets, I want to get your broader view on the market. We are at an 8-month high when it comes to the Nifty. The last time we saw this level was in October. What are your expectations going forward in the next 6 to 12 months? What are the key factors we should be watching out for especially in terms of global cues? Jyotivardhan Jaipuria: Yes, you are right, what we are seeing is like the market has recovered from its lows. The one good thing for us has been India's macros are looking very good. If you think of the twin deficit, that is looking great; inflation is coming down, especially held by oil prices going down; RBI has been very proactive on the monetary policy front. We have a very easy liquidity. Already they have probably pumped in Rs 6-7 lakh crores of liquidity. The macro is looking very good and that is helping us. The valuations are not cheap. Earnings hopefully will recover. We saw some recovery in the March quarter, but still it was like we are still running at less than single digit returns. So, hopefully, this year we will have the forecast of 10% to 11% growth which helps us drive returns. Overall, the concern is global. Basically the deadline of 90 days for the Trump tariffs gets over on the 9th of July and so far, not many deals have got signed. Even India's deal is still a work in process. We do not know whether he puts the reciprocal tariffs back again or if he will go back and say that he will give another 90 days or 60 days for negotiation to happen and so that is one thing which weighs on the market. One positive for the market to the later part of this year and for the Indian market is that MSCI does this review and Korea is up for review again, and whether they will move to a developed status. If that happens, it will be very positive for all the other countries in the emerging market space. India's weightage will probably go up roughly 2% because of that and that will help get flows to the Indian market, so that is a positive from the global which we have to keep an eye on by the end of this month. Let us talk about the sectors then. While there is a common consensus on the banking pack, the NBFCs and the financials, even the valuations look very reasonable. But what are the other sectors that you would be bullish on and what are the bets where you would be taking money off the table? What are the risks that you see in the coming future? Jyotivardhan Jaipuria: Yes, you are right, we also are positive on banks and financials. More or less everybody has turned positive on it. Apart from that, one other sector we are bullish on. Just remember we generally do not go by what is current momentum but what is out of favour, so we have a whole 3 U philosophy which looks at sectors which are under-owned and under-performing. One sector which we have been playing now has been the chemical sector, and that has been out of favour for quite some time. The stocks have not done well for the last two years and there are some interesting ideas which are coming up there, especially because globally, a lot of dealers have destocked chemicals. The stocking level at the dealer-end is close to a two-year low and that is where we see some upside coming through in demand. Here we have to be careful because stocks are still not cheap. So, look for stocks where there is a substantial earnings growth upside over the next two years. But in general, chemicals is one sector we like. The other sector which we like is the cement sector. Cement has not done much in terms of earnings growth, and has been flattish for the last 12-18 months. There has been a lot of consolidation in the sector which probably helps over the next couple of years because it becomes easier to hike prices. Second, government demand should pick up and so for us, there are a lot of interesting ideas to find there. We are getting into the monsoon season which is typically like a lean season for cement. Over the next few weeks, pick up cement stocks on dips. So, those would be two sectors we like. We also like pharmaceuticals, but there we have to be a little careful with Trump's tariffs because there has been a lot of contradictory talk from him. So, be a little careful there. These are very secular growth stories, especially the CDMO pack in the pharma space. Within the pharma space, are there any particular pockets where you find more value than the others? Jyotivardhan Jaipuria: Yes, one of them is the CDMO space where value is not there in the sense these stocks are not cheap and are rather expensive. But for us, over the next three-five years there is lot of visible growth there and so just the sheer growth which we have most companies there could have a growth compounded for the next maybe three-five years or in the range of 25% plus, so that is what is really probably going to drive earnings in the space. None of these stocks are very cheap, so when we look at it, we always think that the valuations have a lot of margin of safety probably, but we are quite confident that the earnings will play out and so that is what we are playing. Now, there are obviously two other spaces in the pharma space, one is domestic pharma and the other is the US generics or in general the global generics. So, we have actually been more positive on the US generic side than on the domestic pharma side because US generics had done quite poorly for four-five years and for us, we were sensing a turnaround. We have been playing US generics for the past 18 months, and that is where there could be a lot of wobble if Trump changes some duties there. But for us, the duties will create temporary dislocation. But Indian generics are really cheap. There would not be a longer-term impact. At some point, the consumer prices in the US will probably go up to reflect the duty changes. So, we would be bullish on US generics on any correction and we like the CDMO space. After the correction that we have seen in the SMIDs, are you comfortable with the valuations? As far as the smallcaps are concerned, there could be an improvement in the earnings growth going ahead. Do you see comfort in buying into smallcaps or would you still be wary of the broader market? Jyotivardhan Jaipuria: When we started the calendar year, it was a very easy call that the largecaps will do better than the smallcaps because that time the valuation disparity was huge. After the correction that we saw in January-February, we became more neutralish. In fact, the tilt became slightly more towards the small and midcaps because like you said the earnings are much stronger for the small and midcaps. Even in the last quarter, the earnings growth for the midcaps was close to 17-18%, the earnings growth for the smallcaps was just about double digit and the earnings growth for the largecaps was more like 5-6%. So, the earnings growth will be sharp and with liquidity coming into the system, earnings growth this year will surprise on the upside for the small and midcap which will drive earnings. At the same time, one should be careful of being a very blanket call because there are a lot of pockets in the small and midcap which are not very cheap. You have to look at valuations a little more closely because this is not like a runaway which we saw post Covid where every smallcap was flying. I would be a little more positive on the smallcaps but be careful of the valuations and look for stocks with earnings visibility. I want to get your overall view on SMIDs. Last time we spoke, you said the next leg of growth is going to be driven by earnings and just before you were mentioning all the sectors that you prefer, they have an earnings upside. Last time you said that 12% recovery in FY26 is what you expect in terms of earnings. Do you still retain that view or has it changed and what is the outlook there? Which are the sectors that are going to drive this growth? Jyotivardhan Jaipuria: We still retain that view that we will get double-digit earnings growth for FY26. As you know, FY25 was a very weak year for earnings, so one is probably the base impact helps and what you will see over the next six months is like a very poor base of government and corporate capex. It will be easier to show growth for a lot of these companies which are dependent on government capex. The other thing that will help is liquidity in the system. Rates are coming down, and that will be very positive for earnings to come through. In terms of, what will help, basically, we will see some of the engineering names and the capital good names continue to do well. Some of the consumer discretionary names will also show strong earnings growth. We will probably see a rebound in some of these commodities, like cement which will play an important role in terms of driving the earnings growth for next year, plus stuff like telecom.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store